Literature DB >> 20140725

Stimulation of protective and cross-protective immunity against influenza B virus after adjuvant mucosal immunization of mice.

L Prokesová1, P Zanvit, M Havlícková, J Tácner, M Jirkovská, P Petrásková, O Novotná, D Cechová, J Julák.   

Abstract

Intratracheal immunization of mice with inactivated influenza B virus and delipidated Bacillus firmus as adjuvant increases protection of mice against infection with the homologous virus strain and induces cross-protection: mice immunized by influenza virus B/Yamanashi 166/98 were protected even against phylogenetically distant virus drift variant B/Lee/40 lethal for mice.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20140725     DOI： 10.1007/s12223-009-0080-z

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN： 0015-5632            Impact factor:   2.099


  10 in total

Review 1.  Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines.

Authors:  Shin-ichi Tamura; Takeshi Tanimoto; Takeshi Kurata
Journal:  Jpn J Infect Dis       Date:  2005-08       Impact factor: 1.362

Review 2.  The perfect mix: recent progress in adjuvant research.

Authors:  Bruno Guy
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

3.  Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages.

Authors:  B Camilloni; M Neri; E Lepri; A M Iorio
Journal:  Vaccine       Date:  2009-05-14       Impact factor: 3.641

4.  Enhanced systemic and mucosal antibody responses to a model protein antigen after intranasal and intratracheal immunisation using Bacillus firmus as an adjuvant.

Authors:  P Mlcková; D Cechová; P Chalupná; O Novotná; L Prokesová
Journal:  Immunol Lett       Date:  2001-05-01       Impact factor: 3.685

5.  Immune response after adjuvant mucosal immunization of mice with inactivated influenza virus.

Authors:  P Zanvit; M Havlícková; J Tácner; M Jirkovská; P Petrásková; O Novotná; D Cechová; J Julák; I Sterzl; L Prokesová
Journal:  Immunol Lett       Date:  2004-11-24       Impact factor: 3.685

6.  Secretory IgA antibodies provide cross-protection against infection with different strains of influenza B virus.

Authors:  Yasuko Asahi-Ozaki; Tomoki Yoshikawa; Yoichiro Iwakura; Yujiro Suzuki; Shin-Ichi Tamura; Takeshi Kurata; Tetsutaro Sata
Journal:  J Med Virol       Date:  2004-10       Impact factor: 2.327

7.  Protective and cross-protective mucosal immunization of mice by influenza virus type A with bacterial adjuvant.

Authors:  Peter Zanvit; Martina Havlícková; Jaroslav Tácner; Olga Novotná; Marie Jirkovská; Dana Cechová; Jaroslav Julák; Ivan Sterzl; Ludmila Prokesová
Journal:  Immunol Lett       Date:  2007-11-29       Impact factor: 3.685

8.  Protection and compensation in the influenza virus-specific CD8+ T cell response.

Authors:  Richard J Webby; Samita Andreansky; John Stambas; Jerold E Rehg; Robert G Webster; Peter C Doherty; Stephen J Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-29       Impact factor: 11.205

9.  Live, attenuated influenza virus (LAIV) vehicles are strong inducers of immunity toward influenza B virus.

Authors:  Victor C Huber; Loren H Kleimeyer; Jonathan A McCullers
Journal:  Vaccine       Date:  2008-08-15       Impact factor: 3.641

10.  Diversifying selective pressure on influenza B virus hemagglutinin.

Authors:  Jun Shen; Brian D Kirk; Jianpeng Ma; Qinghua Wang
Journal:  J Med Virol       Date:  2009-01       Impact factor: 2.327
  10 in total
  1 in total

1.  Immunomodulatory properties of subcellular fractions of a G+ bacterium, Bacillus firmus.

Authors:  Dana Cechova; Michaela Novakova; Karel Mikulik; Olga Novotna; Jaroslav Julak; Peter Zanvit; Ludmila Prokesova
Journal:  Folia Microbiol (Praha)       Date:  2012-08-09       Impact factor: 2.099
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.